No credit card. No commitment.
5000+ G2 reviews
GeneCellNano
Research
Founded in 2019
KuopioGeneCellNano
ResearchFounded in 2019Kuopio
TechnologiesGeneCellNano's financial review
Employees
1
GeneCellNano information
The GeneCellNano Flagship develops new biological drugs, biomarkers and diagnostics for diseases with unmet clinical needs. Our focus areas are cardiovascular diseases, age-related macular degeneration, and cancers of the brain, ovarian and bladder.The Flagship brings together an interdisciplinary team of top researchers specialized in biological Advanced Therapy Medicinal Products (ATMP) and nano...
The GeneCellNano Flagship develops new biological drugs, biomarkers and diagnostics for diseases with unmet clinical needs. Our focus areas are cardiovascular diseases, age-related macular degeneration, and cancers of the brain, ovarian and bladder.The Flagship brings together an interdisciplinary team of top researchers specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechnology for ATMP production.
GeneCellNano industries
Gene therapy
Cellbased therapies
Nanotherapy
Research
GeneCellNano's financial review
Employees
1
Technologies
Fonts
Online Video Platforms
Other
Load Balancers
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
